HTT and glycogen storage disease VI: ,8 This expression of therapeutic miHTT in key brain areas relating to HD results in lowering of HTT mRNA and mutant Htt protein, reduction in mutant Htt aggregates, and improvements in neuronal dysfunction, behavior, and survival in different small and large animal disease models.5, 6, 8